Patients enrolled in select federal health insurance programs could have up to $500 of hemp-derived products covered each ...

The Centers for Medicare & Medicaid Services (CMS) will soon be launching a pilot program that would cover the costs of CBD ...

Two compounds found in cannabis show potent anti-tumor effects when exposed to ovarian cancer cells, suggesting they could play a role in future therapeutic research. Tetrahydrocannabinol (THC) and ...

A study published in JAMA Network Open indicated that cannabidiol (CBD) did not lower scan-related anxiety, but the findings suggested that CBD significantly decreased overall anxiety levels.

A new in vitro study found that cannabidiol (CBD) may effectively treat colorectal cancer, regardless of mutation. The corresponding study was published in ACS Pharmacology & Translational Science.

Please provide your email address to receive an email when new articles are posted on . Cannabidiol may reduce scan-related anxiety among certain women with advanced ...

A new study explores whether cannabidiol (CBD), a component of marijuana, can reduce anxiety levels, specifically among patients with advanced breast cancer before a scan assessing tumor burden. The ...

The findings showed that CBD did not significantly change scan-related anxiety when compared to a placebo, but researchers did find that CBD was safe and resulted in significantly lower overall ...

The findings showed that CBD did not significantly change scan-related anxiety when compared to a placebo, but researchers did find that CBD was safe and resulted in significantly lower overall ...